These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29260264)

  • 1. A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activity.
    Brito AF; Braga PCCS; Moreira LKS; Silva DM; Silva DPB; Sanz G; Vaz BG; de Carvalho FS; Lião LM; Silva RR; Noël F; Neri HFS; Ghedini PC; de Carvalho MF; de S Gil E; Costa EA; Menegatti R
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):255-269. PubMed ID: 29260264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system.
    da Silva DM; Sanz G; Vaz BG; de Carvalho FS; Lião LM; de Oliveira DR; Moreira LKDS; Cardoso CS; de Brito AF; da Silva DPB; da Rocha FF; Santana IGC; Galdino PM; Costa EA; Menegatti R
    Biomed Pharmacother; 2018 Jul; 103():546-552. PubMed ID: 29677541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
    Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
    Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic- and antidepressant-like effects of new phenylpiperazine derivative LQFM005 and its hydroxylated metabolite in mice.
    Moreira LKDS; Silva RR; da Silva DM; Mendes MAS; de Brito AF; de Carvalho FS; Sanz G; Rodrigues MF; da Silva ACG; Thomaz DV; de Oliveira V; Vaz BG; Lião LM; Valadares MC; Gil ES; Costa EA; Noël F; Menegatti R
    Behav Brain Res; 2022 Jan; 417():113582. PubMed ID: 34536431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effect of 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol is mediated through the benzodiazepine and nicotinic pathways.
    Brito AF; Fajemiroye JO; Neri HFS; Silva DM; Silva DPB; Sanz G; Vaz BG; de Carvalho FS; Ghedini PC; Lião LM; Menegatti R; Costa EA
    Chem Biol Drug Des; 2017 Sep; 90(3):432-442. PubMed ID: 28160425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic- and antidepressant-like activities of a methanolic extract of Morinda citrifolia Linn. (noni) fruit in mice: Involvement of benzodiazepine-GABA
    Narasingam M; Vijeepallam K; Mohamed Z; Pandy V
    Biomed Pharmacother; 2017 Dec; 96():944-952. PubMed ID: 29217165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant and anxiolytic effects of the methanol root extract of Capparis thonningii: involvement of monoaminergic, cholinergic and GABAergic systems.
    Ishola IO; Olayemi SO; Yemitan OK; Umeh EA
    Drug Res (Stuttg); 2015 Apr; 65(4):205-13. PubMed ID: 24886981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidepressant- and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice.
    Pytka K; Żmudzka E; Lustyk K; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Barbara F
    Indian J Pharmacol; 2016; 48(3):286-91. PubMed ID: 27298499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential of Parsley Polyphenols and Their Antioxidant Capacity to Help in the Treatment of Depression and Anxiety: An In Vivo Subacute Study.
    Es-Safi I; Mechchate H; Amaghnouje A; Kamaly OMA; Jawhari FZ; Imtara H; Grafov A; Bousta D
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
    Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of monoaminergic system in the antidepressant-like effect of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice.
    de Sousa FC; Oliveira IC; Silva MI; de Melo CT; Santiago VR; de Castro Chaves R; Fernandes ML; Gutierrez SJ; Vasconcelos SM; Macêdo DS; Barbosa Filho JM
    Fundam Clin Pharmacol; 2014 Feb; 28(1):95-103. PubMed ID: 22913717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central pharmacological activity of a new piperazine derivative: 4-(1-phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester.
    de Brito AF; Martins JL; Fajemiroye JO; Galdino PM; De Lima TC; Menegatti R; Costa EA
    Life Sci; 2012 Jun; 90(23-24):910-6. PubMed ID: 22564406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1- Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways.
    Almeida LS; Santana IGC; da Silva Moreira LK; Turones LC; Sanz G; Vaz BG; de Carvalho FS; Lião LM; Menegatti R; Costa EA; de Brito AF
    CNS Neurol Disord Drug Targets; 2022; 21(6):520-532. PubMed ID: 34781873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
    Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological assessment in mice and molecular docking of piperazine derivative LQFM212.
    Moreira LK; de Brito AF; Fontana C; de Carvalho FS; Sanz G; Vaz BG; Lião LM; da Rocha FF; Verli H; Menegatti R; Costa EA
    Behav Brain Res; 2020 Sep; 394():112827. PubMed ID: 32730857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms.
    Can ÖD; Demir Özkay Ü; Üçel Uİ
    Eur J Pharmacol; 2013 Jan; 699(1-3):250-7. PubMed ID: 23099258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.